These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12016691)

  • 1. Decreased psychopathology & family burden. Associated with clozapine treatment of patients with refractory schizophrenia.
    Snyder N; Goldstein G
    J Psychosoc Nurs Ment Health Serv; 2002 May; 40(5):34-9. PubMed ID: 12016691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia.
    Lawrie S; McIntosh A
    Clin Evid; 2002 Jun; (7):920-44. PubMed ID: 12230716
    [No Abstract]   [Full Text] [Related]  

  • 3. Refractory schizophrenia: what works pharmacologically?
    Sousa S
    J Psychosoc Nurs Ment Health Serv; 1999 Feb; 37(2):19-23. PubMed ID: 10023603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine in the treatment of schizophrenia].
    Mark M; Magnezi R; Luxenburg O; Siebzehner M; Shemer J
    Harefuah; 1999 Sep; 137(5-6):185-8, 264, 263. PubMed ID: 10959316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Jurgis G; Perlick D; Xu W; Thomas J; Henderson W; Charney D
    J Clin Psychiatry; 2000 Sep; 61(9):671-6. PubMed ID: 11030488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
    Kämpf P; Agelink MW; Naber D
    Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
    [No Abstract]   [Full Text] [Related]  

  • 7. Schizophrenia.
    Lawrie S; McIntosh A; Nadeem Z
    Clin Evid; 2002 Dec; (8):1019-49. PubMed ID: 12603927
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
    Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
    Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs].
    Galvez-Buccollini JA; Fiestas F; Herrera P; Vega-Dienstmaier JM; Guimas B; Mazzotti G
    Actas Esp Psiquiatr; 2004; 32(4):211-5. PubMed ID: 15232749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?
    Dursun SM; Hallak JE; Haddad P; Leahy A; Byrne A; Strickland PL; Anderson IM; Zuardi AW; Deakin JF
    J Psychopharmacol; 2005 Jul; 19(4):432-3. PubMed ID: 15983003
    [No Abstract]   [Full Text] [Related]  

  • 15. Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia.
    Pinto A; La Pia S; Mennella R; Giorgio D; DeSimone L
    Psychiatr Serv; 1999 Jul; 50(7):901-4. PubMed ID: 10402608
    [No Abstract]   [Full Text] [Related]  

  • 16. Family intervention in schizophrenia--impact on family burden and attitude.
    Berglund N; Vahlne JO; Edman A
    Soc Psychiatry Psychiatr Epidemiol; 2003 Mar; 38(3):116-21. PubMed ID: 12616308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clozapine experience from a family perspective.
    Dickson RA; Williams R; Dalby JT
    Can J Psychiatry; 1995 Dec; 40(10):627-9. PubMed ID: 8681261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 19. A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia.
    Doruk A; Uzun O; Ozşahin A
    Int Clin Psychopharmacol; 2008 Jul; 23(4):223-7. PubMed ID: 18545061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.